Comparing Analgesic Effects of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine

Launched by WOLLO UNIVERSITY · Oct 7, 2023

Keywords

ClinConnect Summary

This clinical trial is trying to find out which method is the best for managing pain after a cesarean section. The study compares three different pain relief options: one group will receive tramadol, another will receive bupivacaine, and a third group will receive a combination of both tramadol and bupivacaine. By comparing these methods, the researchers aim to see which one works best in reducing pain for women who have just had surgery.

To participate in this study, women between the ages of 18 and 35 who have low to moderate health risks (classified as ASA class I-II) may be eligible. However, those with chronic pain, higher health risks, certain medical conditions, known allergies to the medications being studied, or a history of substance abuse will not be included. Participants will be asked to report their pain levels after treatment, which will help the researchers understand how effective each pain relief method is. It's important to note that this trial is not yet recruiting participants, so there will be more information available in the future for those interested in taking part.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women age between 18 and 35
• • ASA risk class I-II
• Exclusion Criteria:
• • - Chronic pain diagnosis
• • ASA above II
• • Comorbidities (Anemia, DM, HTN, Arthritis)
• • Known allergy to bupivacaine, tramadol
• • History of alcohol, opiate, or other drug abuse
• • Use of preoperative anti-pain